C50.92 Catégorie · précision supplémentaire requise Malignant neoplasm of breast of unspecified site, male
ICD-10-CM C50.92 identifies “Malignant neoplasm of breast of unspecified site, male” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapitre 2: Neoplasms
Instructions du code
Aucune note supplémentaire.
Instructions des niveaux supérieurs
C50 · Malignant neoplasm of breast
Includes3
- connective tissue of breast
- Paget's disease of breast
- Paget's disease of nipple
Use additional code1
code to identify estrogen, and other hormones and factors receptor status (Z17.-)
Chapitres 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Codes plus précis
Références de l’index officiel
Références de l’index officiel (25)
Adenocarcinoma (7)
- Adenocarcinoma › duct › infiltrating › unspecified site(female) › maleIndex des maladies
- Adenocarcinoma › infiltrating duct › unspecified site(female) › maleIndex des maladies
- Adenocarcinoma › inflammatory › unspecified site(female) › maleIndex des maladies
- Adenocarcinoma › intraductal › noninfiltrating › papillary › with invasion › unspecified site(female) › maleIndex des maladies
- Adenocarcinoma › intraductal › papillary › with invasion › unspecified site(female) › maleIndex des maladies
- Adenocarcinoma › lobular › unspecified site(female) › maleIndex des maladies
- Adenocarcinoma › papillary › intraductal(noninfiltrating) › with invasion › unspecified site(female) › maleIndex des maladies
Carcinoma-in-situ (2)
Carcinoma(malignant) (15)
- Carcinoma(malignant) › duct(cell) › infiltrating › with lobular carcinoma(in situ) › unspecified site(female) › maleIndex des maladies
- Carcinoma(malignant) › duct(cell) › infiltrating › specified site › unspecified site(female) › maleIndex des maladies
- Carcinoma(malignant) › ductal › with lobular › unspecified site(female) › maleIndex des maladies
- Carcinoma(malignant) › ductular, infiltrating › unspecified site(female) › maleIndex des maladies
- Carcinoma(malignant) › infiltrating › duct › with lobular › unspecified site(female) › maleIndex des maladies
- Carcinoma(malignant) › infiltrating › duct › unspecified site(female) › maleIndex des maladies
- Carcinoma(malignant) › infiltrating › ductular › unspecified site(female) › maleIndex des maladies
- Carcinoma(malignant) › infiltrating › lobular › unspecified site(female) › maleIndex des maladies
- Carcinoma(malignant) › inflammatory › unspecified site(female) › maleIndex des maladies
- Carcinoma(malignant) › intraductal(noninfiltrating) › papillary › with invasion › unspecified site(female) › maleIndex des maladies
- Carcinoma(malignant) › lipid-rich(female) › maleIndex des maladies
- Carcinoma(malignant) › lobular(infiltrating) › with intraductal › unspecified site(female) › maleIndex des maladies
- Carcinoma(malignant) › lobular(infiltrating) › unspecified site(female) › maleIndex des maladies
- Carcinoma(malignant) › medullary › with › lymphoid stroma › unspecified site(female) › maleIndex des maladies
- Carcinoma(malignant) › papillary › intraductal(noninfiltrating) › with invasion › unspecified site(female) › maleIndex des maladies
Disease, diseased (1)
- Disease, diseased › breast › Paget's › male, unspecified sideIndex des maladies
Historique
Historique du code
Dernière modification enregistrée · FY2025
ModifiéInchangé
FY2025
En vigueur dès le
- Instructions héritées modifiées
Malignant neoplasm of breast of unspecified site, male
Catégorie — choisir un code plus précis
CDC/NCHS · FY2025Toutes les éditions (19)
| Toutes les éditions | En vigueur dès le | Historique du code |
|---|---|---|
| FY2016 | 2015-10-01 | Première observation |
| FY2017 | 2016-10-01 | Aucun changement tabulaire |
| FY2018 | 2017-10-01 | Aucun changement tabulaire |
| FY2019 | 2018-10-01 | Aucun changement tabulaire |
| FY2020 | 2019-10-01 | Aucun changement tabulaire |
| FY2020 · April | 2020-04-01 | Aucun changement tabulaire |
| FY2021 | 2020-10-01 | Aucun changement tabulaire |
| FY2021 · 01-01 | 2021-01-01 | Aucun changement tabulaire |
| FY2022 | 2021-10-01 | Aucun changement tabulaire |
| FY2022 · 04-01 | 2022-04-01 | Aucun changement tabulaire |
| FY2023 | 2022-10-01 | Aucun changement tabulaire |
| FY2023 · 04-01 | 2023-04-01 | Aucun changement tabulaire |
| FY2024 | 2023-10-01 | Aucun changement tabulaire |
| FY2024 · 04-01 | 2024-04-01 | Aucun changement tabulaire |
| FY2025 | 2024-10-01 | Instructions héritées modifiées |
| FY2025 · 04-01 | 2025-04-01 | Aucun changement tabulaire |
| FY2026 | 2025-10-01 | Aucun changement tabulaire |
| FY2026 · April | 2026-04-01 | Aucun changement tabulaire |
| FY2027 | 2026-10-01 | Aucun changement tabulaire |
Explorez les codes plus précis de cette catégorie. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.